Instrumento Inactivo

Acciones Biondvax Pharmaceuticals Ltd Other OTC

Acciones

Duración

Período

Estilo

Biondvax Pharmaceuticals : Announces Rights Offering Fully Subscribed at US$20 Million	16/07/19
Biondvax Pharmaceuticals : First Participant Enrolled in Second Cohort of BiondVax’s Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine Trial	08/07/19
Biondvax Pharmaceuticals : European Investment Bank VP attends Signature Event at BiondVax Extending Financing Agreement with BiondVax to €24 million	26/06/19
Biondvax Pharmaceuticals : Patent Covering Manufacturing Process of BiondVax’s M-001 Universal Flu Vaccine Allowed in USA and Japan	18/06/19
Biondvax Pharmaceuticals : Announces Rights Offering in Support of Ongoing Pivotal, Clinical Efficacy Phase 3 Trial of the M-001 Universal Flu Vaccine and Scale Up of Manufacturing Process	10/06/19

Sector

	Varia. 1 de ene.	Capi.
MODERNA, INC.	+41,68 %	50,93 mil M
IQVIA HOLDINGS INC.	-0,40 %	42,12 mil M
LONZA GROUP AG	+49,62 %	42,05 mil M
CELLTRION, INC.	-7,20 %	29,18 mil M
ICON PUBLIC LIMITED COMPANY	+12,87 %	26,02 mil M
ALNYLAM PHARMACEUTICALS, INC.	-21,95 %	18,9 mil M
BIO-TECHNE CORPORATION	+6,97 %	13,21 mil M
UNITED THERAPEUTICS CORPORATION	+24,59 %	12,17 mil M
MEDPACE HOLDINGS, INC.	+29,69 %	12,16 mil M